688393 Guangzhou LBP Medicine Science & Technology
- 20.18
- +0.22+1.10%
Guangzhou LBP Medicine Science & Technology News
Announcement on the expiration of the holdings reduction plan for shareholders holding 5% or more of the shares and the results of reducing their holdings
Announcement on the acquisition of minority shareholders\' shares in holding subsidiaries and related transactions
Announcement of Shareholding Reduction by Shareholder
Simplified Equity Change Report
Notice of Equity Change: Shareholders holding more than 5% of the shares will reduce their shareholdings to 5%.
Announcement on Shareholders with More Than 5% Shareholding's Plan to Reduce Shareholding
Announcement on plans for shareholders holding 5% or more of the shares to reduce their holdings
2023 Annual Equity Distribution Implementation Notice
Legal Opinion of Guangdong Cinda Law Firm on matters relating to the abolition of some restricted stocks in the 2022 Restricted Stock Incentive Plan of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd.
2023 Annual Profit Distribution Plan Announcement
Announcement on the expiration of the shareholding plan period for shareholders holding 5% or more of the shares and the results of the shareholding reduction plan for directors and supervisors
Announcement on the listing and circulation of part of the initial public offering of restricted shares
Additional Notice Concerning Shareholders\' Illegal Reduction in Shareholders\' Shareholdings of the Company and an Apology
Notice on shareholders\' illegal reduction of company stock holdings and apology
An indicative announcement on changes in the rights and interests of shareholders holding 5% or more of the shares and their co-actors reaching 1%
Notice on shareholders\' illegal reduction of company stock holdings and apology
Announcement on the results of the first vesting period granted by the 2022 Restricted Stock Incentive Plan for the first time and the listing of shares
Announcement on shareholders holding 5% or more of the shares and directors and supervisors halfway through the holdings reduction period and the progress of holdings reduction
The company\'s shareholder dividend return plan for the next three years (2023-2025)
2022 Annual Equity Distribution Implementation Notice
Analysis
Price Target
No Data
No Data